IRCT20200407046981N16招募中未知
Randomized, single-dose, crossover comparative bioequivalence study of the Atorvastatin 40 mg tablets produced by Daana pharmaceutical Co versus Lipitor® (Pfizer company) in 24 healthy males under fasting conditions
Daana pharmaceutical company0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- Male
入选标准
- •The weight limit for each volunteer is between 60 and 100 kg.
- •All volunteers must be non-smokers.
- •They must be healthy in terms of liver, kidney, respiratory system, mental and other general health characteristics that will be assessed.
排除标准
- •Known hypersensitivity or idiosyncratic reaction to Atorvastatin or any ingredients.
- •Subjects with BP = 90/60 mm/Hg or BP = 140/90 mm/Hg.
- •Regular smoker who smokes more than ten cigarettes daily.
- •Taking any medicine during two week before dosing.
研究者
相似试验
已完成
不适用
Bioequivalence study of Metoprolol succinate 95 mg ER tablets in 24 healthy male under fasting conditionsIRCT20180620040164N11Actover pharmaceutical co.24
已完成
不适用
bioequivalence study of Metformin 100 mg + Sitagliptin 50 mg tablets in 24 healthy male under fasting conditionsIRCT20180620040164N15Actover co24
尚未招募
Unknown
bioequivalence study of Eplerenone 50 mg tablet in 24 healthy male under fasting conditionsHeart failure.Heart failureIRCT20180620040164N56ACtover Pharmaceutical Co.24
已完成
不适用
Bioequivalence study of zolpidem 10 mg tablet in 24 healthy male under fasting conditionscomparative bioequivalence study of zolpidem 10 mg tablets of Marhamdarou Co. and Sanofi Co..IRCT20180620040164N1Marham daru24
招募中
Unknown
bioequivalence study of Gliclazide 30 mg MR tablet in 24 healthy male under fasting conditionsdiabetes mellitus.Type 1 diabetes mellitusIRCT20180620040164N53ACtover Pharmaceutical Co.24